3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Carcinoma, Non-Small-Cell Lung
3
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Advanced Solid Tumors
2
Solid Tumor
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Neutropenia
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Fever
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Interventions
Carboplatin
42
Etoposide
37
Cisplatin
23
Topotecan
22
Nivolumab
17
pembrolizumab
12
atezolizumab
12
Ipilimumab
10
Paclitaxel
9
durvalumab
8
Irinotecan
8
Radiosurgery
6
Pemetrexed
6
rovalpituzumab tesirine
5
Magnetic Resonance Spectroscopy
5
trioctyl phosphine oxide
4
trilaciclib
4
etoposide phosphate
4
berzosertib
4
Sunitinib
4
Specimen Handling
4
Platinum
4
PM 01183
4
Dexamethasone
4
veliparib
3
tremelimumab
3
olaparib
3
carfilzomib
3
cabozantinib
3
Temozolomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Small Cell Lung Carcinoma
×
Itraconazole
×
Clear all
No trials found.